Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Asian perspective on NAFLD-associated HCC
Terry Cheuk‐Fung Yip, Hye Won Lee, Wah‐Kheong Chan, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 3, pp. 726-734
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Changing epidemiology, global trends and implications for outcomes of NAFLD
Vincent Wai‐Sun Wong, Mattias Ekstedt, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 842-852
Open Access | Times Cited: 271
The Global Burden of Liver Disease
Zobair M. Younossi, Grace Lai‐Hung Wong, Quentin M. Anstee, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 1978-1991
Open Access | Times Cited: 195
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
Terry Cheuk‐Fung Yip, Eduardo Vilar‐Gómez, Salvatore Petta, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1404-1427
Closed Access | Times Cited: 71
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David Le, Thomas C. Baez, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 235-246
Open Access | Times Cited: 24
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 20
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 18
Risk factors for metabolic dysfunction-associated steatotic liver disease in patients with polycystic ovary syndrome in East Asia: a review and meta-analysis
Zhao Wu, Guining Liang, Ying–Jun Angela Zhang, et al.
Endocrine Practice (2025)
Closed Access | Times Cited: 1
Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function
Jiaxin Zhang, Wenxin Zhang, Li Yang, et al.
Phytomedicine (2022) Vol. 109, pp. 154589-154589
Open Access | Times Cited: 47
Melatonin Ameliorates Hepatic Ferroptosis in NAFLD by Inhibiting ER Stress via the MT2/cAMP/PKA/IRE1 Signaling Pathway
Qingyun Guan, Zixu Wang, Keyu Hu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3937-3950
Open Access | Times Cited: 35
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC
Mei‐Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 6, pp. 1275-1285.e2
Closed Access | Times Cited: 13
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes
Yi‐Ting Chen, Tzu-I Chen, Tsai-Hsuan Yang, et al.
The American Journal of Gastroenterology (2024)
Open Access | Times Cited: 11
Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice
Jiali Hu, Shan Li, Xuan Zhong, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25460-e25460
Open Access | Times Cited: 10
Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective
Jialan Wang, Suwen Jiang, Airong Hu, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27325-e27325
Open Access | Times Cited: 9
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese
Jiarui Chen, Ronald Siyi Lu, Candela Díaz-Cañestro, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 791-800
Open Access | Times Cited: 8
MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization
Yu Liu, Chien‐Jen Chen, Xuanxuan Yan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention
Shuangfeng Li, Shuangshuang Yin, Hui Ding, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 35
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis
Pojsakorn Danpanichkul, Cheng Han Ng, Mark Muthiah, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 10, pp. 1062-1074
Open Access | Times Cited: 20
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide
Nicole E. Rich
Surgical Oncology Clinics of North America (2023) Vol. 33, Iss. 1, pp. 1-12
Closed Access | Times Cited: 19
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women
Pojsakorn Danpanichkul, Cheng Han Ng, Mark Muthiah, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 5, pp. 893-909
Closed Access | Times Cited: 17
Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction‐associated steatotic liver disease
Sherlot Juan Song, Asako Nogami, Lilian Yan Liang, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1167-1175
Open Access | Times Cited: 6
MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
Wah‐Kheong Chan, Vincent Wai‐Sun Wong, Leon A. Adams, et al.
Hepatology International (2024) Vol. 18, Iss. S2, pp. 909-921
Closed Access | Times Cited: 5
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
Caffeine Ameliorates Metabolic-Associated Steatohepatitis by Rescuing Hepatic Dusp9
Xin Xin, Cheng Chen, Xiaoxue Xu, et al.
Redox Biology (2025) Vol. 80, pp. 103499-103499
Open Access
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
Yu‐Xian Teng, Si Xie, Pingping Guo, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 955-964
Open Access | Times Cited: 25
Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity
Xingfeng Liu, Kai Wang, Luhai Wang, et al.
Hepatology (2022) Vol. 78, Iss. 2, pp. 562-577
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top